MIRA Pharmaceuticals, Inc.
corporate_fare Company Profile
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for MIRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 8 rated 8 or above. Recent SEC coverage for MIRA spans 10-Q, 8-K.
Recent high-impact activity:
- MIRA Q3 10-Q: Cash Falls to $2.5M, Going-Concern Doubt and Nasdaq Bid-Price Notice
- MIRA's Oral SKNY-1 Cuts Weight and Fat in Obese Mice, With Less Lean-Mass Loss Than Semaglutide
- MIRA-55 Matches Celebrex for Pain Relief in 21-Day Chronic Pain Study
- MIRA Advances Ketamir-2 to Phase 2a in CIPN After FDA Review
- MIRA's Ketamir-2 Clears FDA Review, Heads to IRB for Phase 2a CIPN Trial
Financial Snapshot
Short Interest & Short Volume
1.44 days to coverFINRA reported short interest of 282,319 shares in MIRA as of the October 30, 2026 settlement, a 19.3% decrease from the prior period — about 1.4 days to cover at its recent average daily volume. On November 20, 2026, 21.4% of MIRA volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.